Double maintains 2 strategies that include VRDN - Viridian Therapeutics, Inc.
Yahoo
WALTHAM, Mass., May 07, 2025--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the United States Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to veligrotug ("veli"), the company’s lead anti-insulin-like growth factor-1 receptor (IGF-1R) drug candidate for the treatment of TED.
Yahoo
Viridian Therapeutics ( NASDAQ:VRDN ) First Quarter 2025 Results Key Financial Results Net loss: US$86.9m (loss widened...
Yahoo
WALTHAM, Mass., May 06, 2025--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the first quarter ended March 31, 2025.
Yahoo
WALTHAM, Mass., May 02, 2025--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 204,150 shares of the company’s common stock to 13 new employees (the "
Finnhub
Viridian Therapeutics Inc: * VIRIDIAN THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDERNASDAQLISTING RULE 5635Source text:Further company coverage: ...
Yahoo
WALTHAM, Mass., April 07, 2025--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the appointment of Jeff Ajer to its Board of Directors.
Current Value
$12.631 Year Return
Current Value
$12.631 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -12.78% | $22.95B | +20.67% | 1.12% |
BTCT | -10.01% | $25.35M | +93.08% | 0.00% |
BNED | -8.92% | $371.19M | -38.80% | 0.00% |
CME | -8.07% | $98.74B | +28.80% | 3.84% |
FMTO | -7.73% | $45.74M | -99.96% | 0.00% |
AQB | -5.48% | $2.96M | -61.58% | 0.00% |
MSIF | -5.40% | $715.25M | +28.42% | 7.05% |
PPC | -5.40% | $11.21B | +41.54% | 0.00% |
MNOV | -5.37% | $68.17M | -2.80% | 0.00% |
K | -5.28% | $28.49B | +32.17% | 2.77% |
QNRX | -4.83% | $4.53M | -71.65% | 0.00% |
TSN | -4.78% | $19.43B | -8.67% | 3.56% |
MKTX | -4.78% | $8.01B | -1.42% | 1.39% |
SKWD | -4.76% | $2.53B | +72.53% | 0.00% |
MO | -4.48% | $97.80B | +26.35% | 6.94% |
T | -4.39% | $196.66B | +57.98% | 4.07% |
VSA | -3.69% | $7.04M | -49.24% | 0.00% |
TEF | -3.60% | $27.20B | +8.80% | 6.44% |
DOGZ | -3.36% | $231.95M | +120.05% | 0.00% |
NEUE | -3.15% | $62.05M | +13.56% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBD | -0.06% | $380.12M | 0.43% |
AGZD | 0.42% | $127.42M | 0.23% |
BSMW | -0.77% | $102.62M | 0.18% |
BIL | 0.78% | $45.95B | 0.1356% |
FXE | -0.79% | $525.40M | 0.4% |
UDN | -0.84% | $137.74M | 0.78% |
SPTS | 0.90% | $5.76B | 0.03% |
UTWO | 0.98% | $387.71M | 0.15% |
XBIL | 1.00% | $782.40M | 0.15% |
USDU | -1.18% | $173.44M | 0.5% |
UUP | -1.31% | $292.27M | 0.77% |
FTSD | -1.35% | $212.46M | 0.25% |
AGZ | 1.37% | $607.46M | 0.2% |
DBE | 1.37% | $48.48M | 0.77% |
GSST | 1.41% | $857.21M | 0.16% |
GOVZ | -1.42% | $249.31M | 0.1% |
KCCA | 1.49% | $97.18M | 0.87% |
UNG | -1.53% | $371.83M | 1.06% |
BWX | 1.64% | $1.41B | 0.35% |
SGOV | 1.76% | $45.91B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.71% | $361.41M | 1.43% |
VIXY | -27.50% | $109.64M | 0.85% |
TAIL | -24.34% | $140.49M | 0.59% |
GBIL | -10.56% | $6.17B | 0.12% |
IVOL | -8.29% | $353.94M | 1.02% |
FXY | -8.01% | $838.61M | 0.4% |
TPMN | -7.30% | $31.54M | 0.65% |
CTA | -7.05% | $1.05B | 0.76% |
CLIP | -6.02% | $1.50B | 0.07% |
ULST | -5.97% | $637.77M | 0.2% |
BILS | -4.62% | $3.96B | 0.1356% |
XHLF | -4.32% | $1.46B | 0.03% |
XONE | -4.24% | $603.24M | 0.03% |
TFLO | -4.11% | $7.06B | 0.15% |
TBIL | -3.86% | $5.76B | 0.15% |
TBLL | -3.85% | $2.46B | 0.08% |
BILZ | -3.06% | $876.85M | 0.14% |
IBTF | -2.74% | $2.12B | 0.07% |
IBTG | -2.51% | $1.88B | 0.07% |
UNG | -1.53% | $371.83M | 1.06% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 57.60% | $4.85B | 0.35% |
GNOM | 51.55% | $40.65M | 0.5% |
IBB | 50.99% | $5.22B | 0.45% |
PBE | 49.41% | $214.12M | 0.58% |
ARKG | 49.07% | $944.78M | 0.75% |
IWC | 46.57% | $766.88M | 0.6% |
FBT | 44.94% | $994.71M | 0.56% |
PTH | 44.37% | $96.56M | 0.6% |
BBH | 44.27% | $327.42M | 0.35% |
XPH | 42.98% | $136.58M | 0.35% |
PINK | 42.38% | $131.52M | 0.5% |
IWO | 42.00% | $11.36B | 0.24% |
VTWO | 41.14% | $12.07B | 0.07% |
IWM | 40.94% | $63.95B | 0.19% |
KJAN | 39.84% | $305.13M | 0.79% |
SCHA | 39.09% | $16.91B | 0.04% |
KJUL | 38.84% | $113.35M | 0.79% |
GSSC | 38.69% | $538.65M | 0.2% |
IWN | 38.61% | $11.10B | 0.24% |
KOMP | 38.30% | $2.20B | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MVO | 0.07% | $66.70M | -38.82% | 21.64% |
HEES | 0.08% | $3.52B | +99.54% | 1.15% |
TH | -0.10% | $690.70M | -39.27% | 0.00% |
OHI | 0.24% | $10.52B | +18.48% | 7.38% |
MPAA | 0.47% | $212.48M | +117.00% | 0.00% |
HCI | -0.47% | $1.90B | +62.58% | 0.98% |
DUK | 0.48% | $90.12B | +12.74% | 3.61% |
CIG.C | 0.51% | $2.45B | +9.77% | 0.00% |
PRMB | -0.52% | $12.11B | +56.30% | 1.15% |
KO | 0.58% | $308.23B | +13.09% | 2.75% |
CNK | -0.65% | $3.67B | +78.94% | 0.25% |
GLP | -0.69% | $1.71B | +15.84% | 5.85% |
CI | 0.71% | $82.51B | -8.96% | 1.84% |
SO | 0.78% | $96.04B | +10.08% | 3.29% |
PRPO | -0.85% | $10.84M | +15.14% | 0.00% |
HRZN | -0.90% | - | - | 17.65% |
VHC | -0.91% | $34.69M | +74.89% | 0.00% |
OCFT | 0.91% | $265.28M | +232.26% | 0.00% |
PSQH | -1.10% | $89.26M | -49.87% | 0.00% |
DXCM | 1.11% | $33.59B | -35.05% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 50.64% | $2.06B | -30.04% | 0.00% |
TWST | 45.70% | $1.80B | -35.27% | 0.00% |
OCUL | 45.50% | $1.14B | +14.35% | 0.00% |
ZYME | 44.65% | $810.02M | +22.92% | 0.00% |
BEAM | 44.25% | $1.73B | -27.49% | 0.00% |
APGE | 43.16% | $2.42B | -24.39% | 0.00% |
FATE | 42.79% | $115.78M | -75.60% | 0.00% |
RGNX | 42.02% | $433.39M | -46.03% | 0.00% |
CRBU | 41.88% | $78.11M | -76.60% | 0.00% |
KYMR | 41.80% | $1.95B | -15.67% | 0.00% |
KRYS | 41.61% | $3.77B | -20.42% | 0.00% |
IDYA | 41.40% | $1.52B | -58.32% | 0.00% |
NRIX | 41.25% | $721.19M | -38.57% | 0.00% |
EYPT | 41.24% | $393.60M | -54.31% | 0.00% |
ABCL | 41.19% | $602.94M | -46.56% | 0.00% |
CLDX | 41.12% | $1.33B | -49.67% | 0.00% |
ATXS | 41.02% | $225.17M | -57.69% | 0.00% |
NTLA | 40.97% | $836.43M | -69.14% | 0.00% |
CGEM | 40.95% | $427.27M | -69.59% | 0.00% |
XENE | 40.71% | $2.27B | -26.70% | 0.00% |